학술논문
OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phase of the PREEMPT clinical program
Document Type
Academic Journal
Author
Source
Toxicon. Jun 01, 2013 68 SUPP.C:110-110
Subject
Language
English
ISSN
0041-0101